Vimarsana
Biggest News Aggregation in the World

Doug Maffei News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Doug Maffei. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Doug Maffei Today - Breaking & Trending Today

Seagen Inc. - TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer - Vimarsana News

Seagen Inc. - TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer

Published: December 7, 2023

BOTHELL - Seagen Inc. today announced data from the Phase 3 HER2CLIMB-02 clinical trial of TUKYSA in combination with the antibody-drug conjugate ado-trastuzumab emtansine . The combination showed...

Source: marketscreener.com
Related Topics:
United StatesUniversity Of WashingtonDoug MaffeiRoger DanseySaraa HurvitzDavid CaouetteFred Hutchinson Cancer CenterExchange CommissionNational Comprehensive Cancer NetworkSeagen IncDivision Of HematologyUniversity Of Washington Department MedicineDrug AdministrationBreast Cancer Development ProgramClinical Research DivisionWashington DepartmentSenior Vice PresidentHutchinson CancerChief Medical OfficerConfidence IntervalHazard RatioResponse Evaluation CriteriaSolid TumorsCancer DevelopmentPositive Breast
TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer - Vimarsana News

TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer

Published: December 6, 2023

BOTHELL, Wash.--(BUSINESS WIRE)--Dec 6, 2023--

Source: eagletribune.com
Related Topics:
United StatesUniversity Of WashingtonDoug MaffeiSaraa HurvitzDavid CaouetteRoger DanseyExchange CommissionSeagen IncDrug AdministrationUniversity Of Washington Department MedicineAmerican Cancer SocietyRoche GroupNational Comprehensive Cancer NetworkLab AbnormalitiesBreast Cancer Development ProgramCancer Statistics CenterHead Of The Division HematologyWashington DepartmentSenior Vice PresidentClinical Research DivisionFred Hutchinson CancerChief Medical OfficerConfidence IntervalHazard RatioImportant Safety Information
Seagen (SGEN) Q4 2022 Earnings Call Transcript - Vimarsana News

Seagen (SGEN) Q4 2022 Earnings Call Transcript

Published: February 16, 2023

SGEN earnings call for the period ending December 31, 2022.

Source: fool.com
Related Topics:
United StatesAndy HsiehRaymond JamesJoe CatanzaroStephen WilleySalveen Richter Goldman SachsJessica FyeAndy Hsieh William BlairJoe Catanzaro Piper SandlerJay Olson OppenheimerAndrew BerensSalveen RichterDavid EpsteinGeoff MeachamYige Guo GuggenheimJessica Fye JpmorganJay OlsonGregory RenzaMatthew Harrison Morgan StanleyPiper SandlerPadcev KeytrudaRoger DanseyMatthew HarrisonDane LeoneDane Leone Raymond James
Seagen Inc. (SGEN) Q3 2022 Earnings Call Transcript - Vimarsana News

Seagen Inc. (SGEN) Q3 2022 Earnings Call Transcript

Published: October 28, 2022

SGEN earnings call for the period ending September 30, 2022.

Source: fool.com
Related Topics:
United StatesHong KongUnited KingdomMorgan StanleyGregory RenzaDaiichi SankyoSheldon Chuan BarclaysMichael Schmidt GuggenheimGena WangJessica FyeTammy Kiely Goldman SachsRoger DanseyJay Olson OppenheimerDoug MaffeiAndrew BerensSalveen RichterGeoff MeachamTodd SimpsonGoldman SachsZai LabSeagen IncSociety For Immunotherapy Of Cancer ConferenceExchange CommissionCompany AnalystChip Romp
Seagen Inc. (SGEN) Q2 2022 Earnings Call Transcript - Vimarsana News

Seagen Inc. (SGEN) Q2 2022 Earnings Call Transcript

Published: July 29, 2022

SGEN earnings call for the period ending June 30, 2022.

Source: fool.com
Related Topics:
United StatesCory KasimovAndy HsiehJoe CatanzaroStephen WilleyGena WangSalveen Richter Goldman SachsJoe Catanzaro Piper SandlerAndy Hsieh William BlairJay Olson OppenheimerAndrew BerensShu Zhiqiang BerenbergGena Wang BarclaysSalveen RichterGeoff MeachamJay OlsonAmerica Merrill LynchGregory RenzaClay SiegallMatthew Harrison Morgan StanleyDaiichi SankyoKaren BenjaminZhiqiang ShuPiper SandlerMichael Schmidt Guggenheim